5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Ventricular Trigeminy
Ventricular trigeminy is a cardiac arrhythmia characterized by a repetitive pattern of heartbeats, where every third beat is a premature ventricular contraction (PVC). In this condition, the normal heartbeat is followed by two consecutive PVCs, creating a distinctive three-beat rhythm. This arrhythmia often arises from issues in the heart's electrical system, leading to irregular contractions that can be identified through electrocardiogram (ECG) monitoring. While ventricular trigeminy itself may not always cause noticeable symptoms, its presence can be indicative of underlying heart conditions that may require medical attention. Diagnosis and management are typically guided by healthcare professionals through a combination of patient history, physical examination, and diagnostic tests, with treatment tailored to address the root cause and prevent potential complications.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain